The convening power of clinical ethics committees stems from their reputation for fairness and procedural legitimacy in addressing and resolving ethically complex cases.
AMA J Ethics. 2016; 18(5):540-545. doi:
10.1001/journalofethics.2016.18.5.msoc2-1605.
The DSM-5 Task Force’s handling of the ethical controversy over the bereavement exclusion demonstrates the need for more inclusive deliberative processes.
AMA J Ethics. 2017; 19(2):192-198. doi:
10.1001/journalofethics.2017.19.2.pfor2-1702.
Michael Anderson, PhD and Susan Leigh Anderson, PhD
Two concerns (unknowability of how output is derived from input and overreliance on clinical decision support systems) are main sources of ethical questions about AI in health care.
AMA J Ethics. 2019; 21(2):E125-130. doi:
10.1001/amajethics.2019.125.
Annette Mendola, PhD and Richard L. Gibson, MD, MPH
Because research on the efficacy of approaches to addiction recovery is inconclusive, clinicians should recommend several, including 12-step approaches.
AMA J Ethics. 2016; 18(6):646-655. doi:
10.1001/journalofethics.2016.18.6.sect1-1606.
Jonathan Alhalel, Nicolás Francone, Sharon Post, Catherine A. O’Brian, PhD, and Melissa A. Simon, MD, MPH
Underrepresentation of individuals with limited English proficiency who speak Spanish is ongoing in phase 3 biomedical clinical trials and exacerbates health inequity.
AMA J Ethics. 2022; 24(4):E319-325. doi:
10.1001/amajethics.2022.319.